Colinz Laboratories Limited (BOM:531210)
India · Delayed Price · Currency is INR 51.26
+2.44 (5.00%)
At close: Jul 18, 2025
Colinz Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 65.28 | 70.3 | 71.55 | 69.74 | 61.59 | Upgrade | |
Revenue Growth (YoY) | -7.14% | -1.75% | 2.59% | 13.24% | -19.00% | Upgrade |
Cost of Revenue | 20.9 | 24.46 | 23.94 | 23.74 | 22.29 | Upgrade |
Gross Profit | 44.38 | 45.84 | 47.61 | 46.01 | 39.3 | Upgrade |
Selling, General & Admin | 28.38 | 31.34 | 32.2 | 30.34 | 26.58 | Upgrade |
Other Operating Expenses | 11.04 | 9.08 | 9.09 | 9.8 | 9.38 | Upgrade |
Operating Expenses | 40.74 | 41.72 | 42.57 | 42.16 | 37.88 | Upgrade |
Operating Income | 3.64 | 4.13 | 5.04 | 3.85 | 1.42 | Upgrade |
Interest Expense | -0.42 | -0.37 | -0.52 | -0.76 | -0.87 | Upgrade |
Interest & Investment Income | - | 2.74 | 1.7 | 1.67 | 1.7 | Upgrade |
Other Non Operating Income (Expenses) | 2.98 | 0.01 | 0.02 | 0.04 | 0.2 | Upgrade |
EBT Excluding Unusual Items | 6.19 | 6.5 | 6.24 | 4.8 | 2.45 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | -0.24 | - | - | Upgrade |
Pretax Income | 6.19 | 6.5 | 6 | 4.8 | 2.45 | Upgrade |
Income Tax Expense | 1.23 | 1.64 | 1.42 | 1.41 | 0.38 | Upgrade |
Net Income | 4.97 | 4.87 | 4.57 | 3.39 | 2.08 | Upgrade |
Net Income to Common | 4.97 | 4.87 | 4.57 | 3.39 | 2.08 | Upgrade |
Net Income Growth | 2.03% | 6.41% | 34.81% | 63.44% | 59.15% | Upgrade |
Shares Outstanding (Basic) | 3 | 3 | 3 | 5 | 5 | Upgrade |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 5 | 5 | Upgrade |
Shares Change (YoY) | -0.04% | 0.34% | -45.19% | -0.61% | 0.93% | Upgrade |
EPS (Basic) | 1.97 | 1.93 | 1.82 | 0.74 | 0.45 | Upgrade |
EPS (Diluted) | 1.97 | 1.93 | 1.82 | 0.74 | 0.45 | Upgrade |
EPS Growth | 2.07% | 6.04% | 145.95% | 64.44% | 57.68% | Upgrade |
Free Cash Flow | -17.16 | 10.35 | 4.03 | 4.3 | 20 | Upgrade |
Free Cash Flow Per Share | -6.81 | 4.10 | 1.60 | 0.94 | 4.34 | Upgrade |
Gross Margin | 67.98% | 65.21% | 66.54% | 65.97% | 63.81% | Upgrade |
Operating Margin | 5.58% | 5.87% | 7.04% | 5.52% | 2.30% | Upgrade |
Profit Margin | 7.61% | 6.92% | 6.39% | 4.87% | 3.37% | Upgrade |
Free Cash Flow Margin | -26.28% | 14.72% | 5.63% | 6.16% | 32.48% | Upgrade |
EBITDA | 4.95 | 5.43 | 6.33 | 5.86 | 3.33 | Upgrade |
EBITDA Margin | 7.58% | 7.72% | 8.84% | 8.40% | 5.41% | Upgrade |
D&A For EBITDA | 1.31 | 1.3 | 1.29 | 2.01 | 1.91 | Upgrade |
EBIT | 3.64 | 4.13 | 5.04 | 3.85 | 1.42 | Upgrade |
EBIT Margin | 5.58% | 5.87% | 7.04% | 5.52% | 2.30% | Upgrade |
Effective Tax Rate | 19.83% | 25.16% | 23.74% | 29.36% | 15.33% | Upgrade |
Revenue as Reported | 68.26 | 73.05 | 73.27 | 71.45 | 63.5 | Upgrade |
Advertising Expenses | - | 0.11 | 0.16 | 0.11 | 0.06 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.